JIMRO Co Ltd - Company Review
JIMRO Co Ltd - Company ReviewSummary
JIMRO Co Ltd (JIMRO), a subsidiary of Otsuka Holdings Co Ltd is a medical device company that provides research and development of medical devices. The company offers products on immune disorders. It also offers despite striking that provides medicine for refractory autoimmune diseases. JIMRO offers adacolumn and PTCA baloon catheter products. The company's adacolumn is used for treating rheumatoid arthritis, systemic lupus erythematosus and behcet's disease. The company also provides articles of therapeutic apheresis and dialysis, and journal of the International Society for Apheresis. JIMRO is headquartered in Takasaki, Japan.
This comprehensive company report of JIMRO Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.